tm logo
APTEVO BIOTHERAPEUTICS
Dead/Abandoned
ABANDONED - NO STATEMENT OF USE FILED

no statement of use filed

on 19 Oct 2020

Last Applicant/ Owned by

SUITE 1050

SEATTLE

WA

98121

Serial Number

86859161 filed on 28th Dec 2015

Registration Number

N/A

Correspondent Address

Monica Riva Talley

STERNE, KESSLER, GOLDSTEIN & FOX P.L.L.C

1100 New York Avenue, N.W.

WASHINGTON DC 20005-6125

Filing Basis

1. intent to use

2. intent to use current

Disclaimer

"BIOTHERAPEUTICS"

APTEVO BIOTHERAPEUTICS

Research and development in the pharmaceutical and biotechnology fields, none of the foregoing related to oncology Pharmaceutical preparations for the treatment and prophylaxis of infectious diseases, immune system diseases and disorders, autoimmune system diseases, and blood disorders, none of the foregoing related to oncology "BIOTHERAPEUTICS"

Classification Information


Class [005]
Pharmaceutical Products


Pharmaceutical preparations for the treatment and prophylaxis of infectious diseases, immune system diseases and disorders, autoimmune system diseases, and blood disorders, none of the foregoing related to oncology

Class [042]
Computer & Software Services & Scientific Services


Research and development in the pharmaceutical and biotechnology fields, none of the foregoing related to oncology

Mark Details


Serial Number

No 86859161

Mark Type

No Service Mark

Attorney Docket Number

No 3479.2420000

44D Filed

No

44D Current

No

44E filed

No

44E Current

No

66A Filed

No

66A Current

No

Current Basis

No

No Basis

No

Legal History


Show more

Status DateAction Taken
19th Oct 2020ABANDONMENT - NO USE STATEMENT FILED
19th Oct 2020ABANDONMENT NOTICE E-MAILED - NO USE STATEMENT FILED
21st Mar 2020NOTICE OF APPROVAL OF EXTENSION REQUEST E-MAILED
20th Mar 2020EXTENSION 5 GRANTED
19th Mar 2020CASE ASSIGNED TO INTENT TO USE PARALEGAL
12th Mar 2020EXTENSION 5 FILED
12th Mar 2020TEAS EXTENSION RECEIVED
06th Sep 2019NOTICE OF APPROVAL OF EXTENSION REQUEST E-MAILED
04th Sep 2019EXTENSION 4 GRANTED
04th Sep 2019TEAS EXTENSION RECEIVED